Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

An Australian mainstream genetic testing program: Clinicians views about current and future practices

20 Nov 2023

Abstract excerpt

PURPOSE: Germline genetic testing results can guide treatment decisions for oncology patients and are now offered to many cancer patients. Mainstream testing refers to genetic testing arranged by a non-genetics specialist. This repeated cross-sectional study aimed: (1) to capture clinician views on the existing mainstreaming genetic testing program for ovarian, breast, prostate, and endometrial cancer patients,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA gene mutations in cancer
Share to PARP inhibition in cancer therapy
Share to Prenatal Screening and Diagnostics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37985938
DOI: 10.1111/ajco.14033

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

An Australian mainstream genetic testing program: Clinicians views about current and future practicesPMID 37985938Read ↗

Evaluation of a mainstream genetic testing program for women with ovarian or breast cancer.Semantic proximity Read ↗

Positive experiences of healthcare professionals with a mainstreaming approach of germline genetic testing for women with ovarian cancerSemantic proximity Read ↗

Breast cancer specialists’ experiences and attitudes towards mainstream genetic testing for patients with breast cancerSemantic proximity Read ↗

Mainstreaming of clinical genetic testing: A conceptual frameworkSemantic proximity Read ↗

Uptake and acceptability of a mainstreaming model of hereditary cancer multigene panel testing among patients with ovarian, pancreatic, and prostate cancer.Semantic proximity Read ↗

Mainstream genetic testing for women with ovarian cancer provides a solid basis for patients to make a well-informed decision about genetic testingSemantic proximity Read ↗

Australians’ views and experience of personal genomic testing: survey findings from the Genioz studySemantic proximity Read ↗

Psychosocial experiences and outcomes for individuals with breast cancer after mainstream genetic testingSemantic proximity Read ↗

Mainstream consent programs for genetic counseling in cancer patients: A systematic review.Semantic proximity Read ↗

A pilot study investigating feasibility of mainstreaming germline BRCA1 and BRCA2 testing in high-risk patients with breast and/or ovarian cancer in three tertiary Cancer Centres in Ireland.Semantic proximity Read ↗

Mainstream genetic testing for breast cancer patients: early experiences from the Parkville Familial Cancer CentreSemantic proximity Read ↗

Genomic test stewardship at scale: retrospective evaluation of a statewide public health serviceSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.